School of Medicine
Showing 6,001-6,050 of 13,032 Results
-
Fadi George Lakkis
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI study how the immune system rejects transplanted organs, with the goal of improving long-term transplant outcomes. A related area of research in my laboratory is the relationship between maternal-fetal immune interactions and reproductive success.
https://pubmed.ncbi.nlm.nih.gov/?term=Lakkis+FG%5BAuthor%5D&sort=date -
Rayhan A. Lal, MD
Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)
BioI grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.
-
Shoeb Lallani
Resident in Adult Neurology
Affiliate, Department FundsBioStanford Neurology Residency 2026 | Research in Schnitzer Lab | Interested in basal ganglia circuity and identification of molecular markers to serve as therapeutic targets for the treatment of movement disorders
-
Mable Lam
Instructor, Neurosurgery
Current Research and Scholarly InterestsMyelin is required for rapid nerve signaling by insulating axons to accelerate action potential propagation. Myelin-forming cells of the central nervous system, called oligodendrocytes, orchestrate one of the most complex morphological transformations in neurobiology. Each oligodendrocyte can extend multiple processes that selectively wrap axons in tens to hundreds of spiraling membrane layers, forming myelin sheaths that vary in thickness and length. Furthermore, oligodendrocytes can respond to neural activity by adding new sheaths or by changing the geometry of pre-existing sheaths to tune neural circuitry, a process known as adaptive myelination.
What are the membrane trafficking mechanisms that drive adaptive myelination in oligodendrocytes?
How can these mechanisms be stimulated to promote myelin regeneration in disease?
By using transgenic mouse models and primary oligodendrocytes, we have found that SNARE-mediated exocytosis drives membrane addition in myelin sheaths. Current research is focused on how these pathways in oligodendrocytes may be regulated during adaptive myelination. -
Vinh Lam
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Vinh Lam is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population health. He earned his MD from the David Geffen School of Medicine at UCLA and chose to stay in Los Angeles to complete his family medicine residency training at UCLA. During his training, Dr. Lam developed a strong interest in teaching and medical education through his involvement with resident education and the graduate medical education committee. He also spent 1 year as a resident informaticist where he also became very interested in informatics, medical technology, and innovative solutions to improving patient health outcomes and decreasing physician burnout. Dr. Lam enjoys caring for patients of all ages from pediatrics to geriatrics, performing office-based procedures, and prioritizing preventative care.
Outside of medicine, Dr. Lam loves to travel with his family, dabbles in photography and videography, and enjoys attempting to recreate meals he has had while traveling with his wife. -
Tracy Lam-Hine
Postdoctoral Scholar, Epidemiology
BioTracy Lam-Hine (he/him), DrPH, MBA, is a postdoctoral scholar in the Department of Epidemiology and Population Health and the Center for Population Health Sciences, a Research Education Component Fellow at the Stanford Alzheimer's Disease Research Center, and is affiliated via a Research Fellowship with the Temple University Center for Public Health Law Research. Dr. Lam-Hine is a social epidemiologist and population health scientist, studying how exposure to adverse childhood experiences, policy environments, and mid-life chronic disease burden shape the risk cognitive and functional aging in later life. Within this broad research area, he has a special focus on the health and social experiences of the US Multiracial population, surveillance data, methods to improve descriptive and population-generalizable research.
-
Tenzin D. Lama, DNP, NP, CNL
Affiliate, Adult Neurology
BioTenzin Lama received her DNP (Doctor of Nursing Practice) with Family Nurse Practitioner degree from University of San Francisco. She has also received her MSN- CNL (Clinic Nurse Leader) from the same university. Tenzin joined the Stanford Comprehensive Epilepsy Center in 2016 and has been working as a Nurse Practitioner in providing care and coordination of services for patients with Epilepsy.
-
Emmet Lamb
Professor of Gynecology and Obstetrics, Emeritus
BioSee Curriculum Vitae
-
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
On Leave from 05/02/2026 To 05/31/2026Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
-
Nathalie Lambrecht
Postdoctoral Scholar, General Internal Medicine
Current Research and Scholarly InterestsDr. Lambrecht's research aims to address malnutrition and environmental degradation from two angles: (1) evaluating climate-resilient agricultural strategies to improve global food security, nutrition, and health, and (2) assessing approaches to promote consumption of healthy and sustainable diets.
Climate-resilient agriculture for human health: Across various countries in Sub-Saharan Africa and South Asia, Dr. Lambrecht investigates small-scale crop and livestock agroecology as a win-win strategy to benefit human nutrition, the environment, and households’ resilience to climate change. Her current work aims to understand whether integrated crop-livestock rearing can buffer the potential negative impacts of climate shocks on children's growth in Ethiopia, Tanzania, Malawi, and Uganda. During her PhD, Dr. Lambrecht examined linkages between household livestock ownership and anemia in children in southern Ghana, investigating the hypothesis that rearing livestock could alleviate anemia by providing a source of micronutrient-rich animal-source foods, yet could also exacerbate anemia by exposing children to zoonotic pathogens. Dr. Lambrecht has also worked on a large-scale homestead food production trial in Bangladesh, examining impacts on agricultural production, and children's and women's diets and health.
Healthy and sustainable diets: Shifting diets towards sustainable and healthy plant-forward dietary patterns is essential for mitigating climate change, reducing biodiversity loss and habitat destruction, and reducing non-communicable chronic diseases. Dr. Lambrecht is a lead researcher of the NURISHD (NURsing home and hospital food service – Implementation of Healthy and Sustainable Diets) study. This research project examines the environmental footprint and nutritional quality of food service in German healthcare institutions and evaluates the feasibility of shifting dietary patterns toward the Planetary Health Diet. -
Dany Lamothe, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Dany Lamothe is a board-certified, fellowship-trained psychiatrist with Stanford Health Care Gastrointestinal Behavioral Medicine. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Medical Psychiatry at Stanford University School of Medicine. He is the lead psychiatrist in the Gastrointestinal Behavioral Medicine Program and the medical director of psychiatric emergency services at Stanford Health Care. In addition, Dr. Lamothe is a supervisor of the Outpatient Psychiatry Clinic.
Dr. Lamothe specializes in addressing emotional, behavioral, and psychological factors that contribute to persistent gastrointestinal symptoms. He uses evidence-based therapies and medication management to help improve his patients’ quality of life.
Dr. Lamothe’s research interests include health anxiety, nutritional support outcomes in patients with gastroparesis, and integrative care models for disorders of gut-brain interaction.
Dr. Lamothe has published his research in peer-reviewed journals such as the Journal of the Academy of Consultation-Liaison Psychiatry, the Canadian Journal of Bioethics, and General Thoracic and Cardiovascular Surgery. He has also presented his research at international, national, and regional meetings, including the annual meetings of the Academy of Consultation-Liaison Psychiatry (ACLP), the American Psychiatric Association (APA), the Association for the Advancement of Philosophy and Psychiatry (AAPP), and the European Association of Psychosomatic Medicine (EAPM).
Dr. Lamothe is a member of the American Academy of Psychodynamic Psychiatry and Psychoanalysis, the ACLP, the APA, the Canadian Psychiatric Association, the EAPM, the International Experiential Dynamic Therapy Association (IEDTA), and the Society for Biopsychosocial Science and Medicine (SBSM). -
Linda (Yu-Ling) Lan
Basic Life Research Scientist, Genetics
BioLinda Lan, DVM, PhD is a postdoctoral fellow in the Snyder Lab. Her research focuses on understanding long-term illness post-acute infections by using a combination of different types of data (multi-omics) and wearable technologies. Currently, Linda is working on three projects.
The first project involves studying the shared mechanisms of long COVID, ME/CFS, and PTLDS using smartwatches and micro-sampling. The second project involves examining the role of autoantibodies in long COVID patients and COVID vaccine side effects. The third project involves exploring the changes in the molecular and physiological responses of astronauts during short space flights using multi-omics and wearable devices.
Linda previously conducted her PhD research at the University of Chicago, where she studied memory B cell responses to a chimeric-based universal influenza virus vaccine candidate. In her leisure time, she enjoys running, hiking, and listening to audiobooks. -
Lukas D. Landegger
Clinical Instructor, Otolaryngology (Head and Neck Surgery)
BioDr. Landegger is a clinician-scientist (otolaryngologist-head and neck surgeon) and Instructor at Stanford University School of Medicine. After gaining clinical as well as research experience in various countries (US, UK, France, Spain, Germany, Singapore, Australia), he specialized in otology with translational hearing research in Vienna, Austria and for five years in Boston (Mass Eye and Ear, Harvard Medical School), leading to a PhD in Neuroscience. Apart from clinical projects, current basic research foci are funded by a grant obtained from the American Society of Gene & Cell Therapy and include inner ear gene therapy, vestibular schwannoma, noise-induced hearing loss, and others.
-
Matthew Landry
Member, Maternal & Child Health Research Institute (MCHRI)
BioCurrent research focuses on identifying the optimal diet (or diets) for chronic disease prevention and addressing the challenges of designing, implementing and reporting clinical trials that test dietary patterns. Particularly interested behavioral interventions that promote plant-forward and plant-based diets. Passionate advocator for policies that address nutrition-related health inequalities particularly in low resource settings and/or with communities experiencing health inequalities related to food insecurity and structural disparities.
Assistant Professor of Population Health and Disease Prevention at University of California, Irvine (effective July 1, 2023) -
Alfred Lane
Professor of Dermatology and of Pediatrics at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDeveloping gene therapy for genetic skin diseases is my major focus. Prior to that, we are developing methods to give effective and efficient care to infants with rare and disabling genetic skin diseases including epidermolysis bullosa and ichthyosis as well as infants and children with unusual and difficult to manage vascular malformations. I am also interested in clinical studies within the NICU protecting premature infants skin and clinical studies in children with common skin diseases.
-
Barton Lane
Professor of Radiology (Diagnostic Radiology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsAs a professor in the Medical Center Line, my primary investigative interest has been in clinical neuroradiology. This encompasses spinal cord and spine disease, degenerative and demyelinating diseases of the central nervous system, strokes and infarction, and chronic epilepsy syndromes. Facial and head and neck vascular malformations and hemangiomas have been a focus of interest for many years, with collaborative projects involving dermatology and functional restoration services.
-
Curtis Langlotz
Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine, of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health and, by courtesy, of Urology
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.
